{"id":"W2567822129","doi":"10.1016/j.jtho.2016.11.2090","title":"PUB119 Lanreotide in Patients with Lung Neuroendocrine Tumors: The Randomized Double-Blind Placebo-Controlled International Phase 3 SPINET Study","year":2017,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Lanreotide; Medicine; Neuroendocrine tumors; Clinical endpoint; Internal medicine; Oncology; Placebo; Phases of clinical research; Lung cancer; Lung; Chemotherapy; Randomized controlled trial; Gastroenterology; Surgery; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001805385,0.0002638308,0.001716102,0.0005223473,0.000177362,0.0001389455,0.0009097682,0.00001146169,0.0001515585],"category_scores_gemma":[0.003191319,0.000136581,0.0002453255,0.0001296106,0.0003395824,0.000513931,0.0002304663,0.001119277,0.00000825973],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002453882,"about_ca_system_score_gemma":0.000414375,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005107994,"about_ca_topic_score_gemma":0.0001412267,"domain_scores_codex":[0.9961908,0.0008753362,0.001190679,0.0002790744,0.001006884,0.0004571964],"domain_scores_gemma":[0.9959491,0.0008068196,0.001791321,0.0005744162,0.0006417465,0.0002365438],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9000601,0.003944905,0.07168197,0.0000235492,0.0005646892,0.0192745,0.00009016859,0.00006495365,0.00003099321,0.00001125689,0.0004510795,0.003801835],"study_design_scores_gemma":[0.9554164,0.00738775,0.03173064,0.0001312675,0.0004888583,0.002835902,0.0002436926,0.0003841299,0.0001071554,0.00004498467,0.001109744,0.0001194158],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9793049,0.00008254222,0.00001987269,0.01359219,0.0007524356,0.004312701,0.000004315275,0.00001205495,0.001919013],"genre_scores_gemma":[0.9978384,0.00004278267,0.0003170536,0.0002539408,0.0005276817,0.0001490461,0.000005180565,0.00003263499,0.0008332682],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05535635,"threshold_uncertainty_score":0.5569614,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03275642882209268,"score_gpt":0.4543495624240792,"score_spread":0.4215931336019865,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}